CommercialCoverageMedium impact
Invasive Prenatal (Fetal) Diagnostic Testing
Blue Cross & Blue Shield of Mississippi·MS · OB-GYN, Family Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has updated their policy for invasive prenatal (fetal) diagnostic testing, establishing specific criteria for chromosomal microarray testing, molecular diagnosis of single-gene disorders, and next-generation sequencing. This policy provides a framework for evaluating clinical utility and coverage of invasive prenatal genetic testing procedures.
Action Required
Review current billing practices for invasive prenatal diagnostic testing procedures including chromosomal microarray testing and next-generation sequencing. Verify that claims include appropriate documentation supporting medical necessity based on increased fetal risk from prenatal screening or other risk factors. Ensure proper procedure coding aligns with the updated policy framework for coverage determination.